share_log

Standard BioTools Q1 2024 GAAP EPS $(0.27) Misses $(0.12) Estimate, Sales $45.540M Miss $46.006M Estimate

Benzinga ·  May 8 16:26

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.12) by 125 percent. This is a 28.57 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $45.540 million which missed the analyst consensus estimate of $46.006 million by 1.01 percent. This is a 81.30 percent increase over sales of $25.119 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment